Day: September 3, 2021

In accordance with the resolution of the Extraordinary General Meeting of Shareholders of AS Ekspress Grupp from 13 July 2021, AS Ekspress Grupp and OÜ Trükitung concluded a share sales agreement on 3rd September 2021, according to which Ekspress Grupp will sell all shares that it owns in Printall (registry code 10092701) to Trükitung OÜ under the following basic conditions:The share sales agreement is based on enterprise value of EUR 10 million, i.e. as at the closing available cash will be added and loan obligations will be deducted from the aforesaid amount; EUR 1 million of the sales price will depend on the results of the financial year 2025 of Printall, including the deferred part of the sales price in the amount of EUR 700,000 which will be paid after the financial results of Printall in 2025 are known; Ekspress Grupp and Printall...

Bekaert to implement a liquidity contract   Bekaert announces that it has entered today into a liquidity agreement with Kepler Cheuvreux relating to its ordinary shares admitted to trading on Euronext Brussels (ISIN Code BE0974258874). This agreement provides for the purchase and sale by Kepler Cheuvreux of Bekaert shares on the regulated market of Euronext Brussels. Kepler Cheuvreux will be acting in the name and on behalf of Bekaert and within the framework of a discretionary mandate, as authorized by the Extraordinary General Meeting of Bekaert of 13 May 2020. In accordance with the conditions specified by this Extraordinary General Meeting (i) the total number of own shares held by Bekaert pursuant to such authorization shall never exceed twenty per cent of the total number of Bekaert shares outstanding and (ii) the acquisitions of...

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, 3 September 2021 – Tecan Group Ltd. (“Tecan Group” or “Tecan”, SIX Swiss Exchange: TECN) has successfully placed 650,000 new registered shares (the “New Shares”) with a par value of CHF 0.10 each in a private placement by way of an accelerated bookbuilding process (the “Share Placement”). The issue price was set at CHF 550 per share (the “Issue Price”), resulting in gross proceeds of CHF 357.5 million. The net proceeds from the Share Placement will be used to partly refinance...

CLEVELAND, Sept. 02, 2021 (GLOBE NEWSWIRE) — Vitality Biopharma, Inc. (OTC Mkts: VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the therapeutic powers of cannabinoids, today announced that the Securities and Exchange Commission has declared the Company’s Form S-1 registration statement effective. The registration statement was filed pursuant to the Securities Purchase Agreement, dated as of August 19, 2021, entered into by the Company with Triton Funds LP (“Triton”) and its affiliate, Triton Funds LLC. The registration statement registers for resale the securities to be issued to Triton under an equity line financing of up to $5,000,000. Only Triton may use the related prospectus to resell the shares registered under the registration statement. The Company anticipates using...

LA JOLLA, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova will participate in the virtual Morgan Stanley 19th Annual Global Healthcare Conference which will be held from September 9 – 15, 2021.  Yuichi Iwaki, MD, PhD, President and Chief Executive Officer, and Geoffrey O’Brien, JD/MBA, Vice President and Executive Officer, will be available for one-on-one meetings at this conference and investors may request a one-on-one meeting through Morgan Stanley. About MediciNova MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for inflammatory, fibrotic,...

HOUSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2021. As of August 31, 2021, the Fund’s net assets were $414 million and its net asset value per share was $8.77. As of August 31, 2021, the Fund’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 505% and the Fund’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 369%.   Kayne Anderson NextGen Energy & Infrastructure, Inc.Statement of Assets and LiabilitiesAugust 31, 2021(Unaudited)  (in...

HOUSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2021. As of August 31, 2021, the Company’s net assets were $1.1 billion, and its net asset value per share was $8.89. As of August 31, 2021, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 491% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 371%.Kayne Anderson Energy Infrastructure Fund, Inc.Statement of Assets and LiabilitiesAugust 31, 2021(Unaudited)    (in...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (NEO: LGIQ) (the “Company” or “Logiq”), a global provider of award-winning e-commerce and fintech solutions, has announced that it has granted and issued a total of 1,242,187 common stock under its equity incentive plan to certain employees and consultants of the Company (the “Stock Awards”). All of the above mentioned Stock Awards were issued at a deemed price of C$5.20 per share pursuant to a Registration Statement on Form S-8 under the U.S. Securities Act of 1933, as amended. 32,000 of the Stock Awards were issued to Brent Suen, the President of the Company, and 100,000 of the Stock Awards were issued to Haig Newton, the President of the Company’s DataLogiq division. The Stock Awards...

TORONTO, Sept. 02, 2021 (GLOBE NEWSWIRE) — MJardin Group, Inc. (CSE: MJAR) (OTCQX: MJARF) (the “Company” or “MJardin”), a leader in premium curated cannabis production and distribution announces the following executive changes. Effective immediately, Pat Witcher has resigned as the Company’s Chief Executive Officer to pursue other interests. The board of directors (the “Board”) and management of the Company thank Pat for his years of service to MJardin during the Company’s formative years, and the many initiatives he led on behalf of the Company. Pat will remain as a director of MJardin where he will continue to support the Company during its previously announced restructuring process. The Board has appointed Mr. Anthony Dutton, a current MJardin board member, as interim Chief Executive Officer of the Company while it completes...